Concurrences Special Issue

We are pleased to have co-authored the foreword for the e-Competitions Special Issue on Healthcare, which is out today. This now available online for all e-Competitions subscribers. National health systems in Europe, which were severely stretched by the Covid-19 pandemic and non-emergency healthcare services, including primary care and planned hospital care, are yet to recover….

Understanding past merger remedies – 2023 update

The Competition and Markets Authority has just published its latest evaluation of past merger remedies. We at Aldwych Partners and NOCON were pleased to contribute to the CMA’s review by carrying out an evaluation of several recent carve-out remedies. A copy of our report and the CMA’s overarching report can be found here.

CMA review of UK fuel retailing

Last Sunday, the Competition and Markets Authority (CMA) was asked by the Government to conduct “an urgent review of competition in the fuel market“, a request driven by rapidly increasing fuel prices and the seeming lack of any benefit to car owners of the Government’s VAT cut on fuel. The 7 July deadline for the…

Children’s nurseries: what chance a CMA review?

Children’s nurseries has been, for some time now, quite low down in Aldwych Partners’ assessment of where CMA intervention risk lies in the health and care sector. The industry appears highly fragmented with more than 27,000 sites and, according to Nursery World, only 1,700 owned by the 25 largest operators. Developments in recent months, however,…

How concentrated is UK vet practice ownership?

In a blog post a couple of days ago we re-visited our earlier analysis of ownership concentration in UK vet care to take account of the CMA’s findings on CVS’s acquisition of The Vet. (The CMA has competition-related concerns in five of the eight local markets where The Vet has practices.) We concluded, subject to…

Aldwych Partners white paper front cover-480

Guides, White Papers & Research

Buy-and-Build Strategies: Managing the risk of UK Competition and Markets Authority intervention

This paper draws on our experience as former competition regulators, and our research on buy-and-builds, to identify opportunities that can mitigate the risk of CMA intervention for these platforms.

It contains practical advice around:

  • The likelihood of deals being called-in by the CMA
  • Influencing the CMA’s view of a market
  • How to best engage with the CMA
  • Drivers of CMA review costs

Fill in your details to receive your copy:

By completing this form you agree to our privacy policy.
We will never share your details with anyone.